Entasis Therapeutics Holdings Inc. (ETTX) Stock Analysis
DELISTED 2022
What happened to Entasis Therapeutics Holdings Inc. (ETTX) stock?
Entasis Therapeutics Holdings Inc. (ETTX) no longer trades on public markets. It was delisted in July 2022. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2022
- Last recorded price (historical):
- $2.19 (last quote on record before the July 2022 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Entasis Therapeutics Holdings Inc. (ETTX). Entasis Therapeutics Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel antibacterial therapies to combat multidrug-resistant infections.
Last analyzed: Jun 14, 2026Entasis Therapeutics Holdings Inc. (ETTX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ETTX shares?
No. ETTX stopped trading on public markets in July 2022, so the shares are not available through a broker. Anything you see quoted for ETTX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ETTX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Entasis Therapeutics Holdings Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.